CNS & Neurological Disorders - Drug Targets

(Formerly 'Current Drug Targets - CNS & Neurological Disorders')

ISSN: 1871-5273 - Volume 7, 6 Issues, 2008

Editor-in-Chief:

Margaret Bradbury, PhD
Auspex Pharmaceuticals
1261 Liberty Way, Ste C
Vista, 92081 CA
USA
Tel: 760-599-1800 x33
E-mail: mbradbury@auspexpharma.com

Co-Editors:

Claire F. Evans (Ichor Medical Systems, San Diego, CA, USA)
John H. Kehne (Neurogen Corporation, Branford, CT, USA)
Stephen D. Skaper (GlaxoSmithKline R & D Ltd, Harlow, UK)
Jeffrey M. Witkin (Eli Lilly and Company, Indianapolis, IN, USA)

Editorial Advisory Board:

Paul Alewood (University of Queensland, Queensland, Australia)
Gjumrakch Aliev ( University of Texas, San Antonio, TX, USA)
Carrolee Barlow (Salk Institute, San Diego, CA, USA)
Bruce M. Baron (Aventis Pharmaceuticals Inc., Bridgewater, NJ, USA)
Philippe Bey (ArQule Inc., Woburn, MA, USA)
Konrad Beyreuther (University of Heidelberg, Heidelberg, Germany)
John B. Bremner (University of Wollongong, Wollongong, Australia)
Steven J. Busch (Aventis Pharmaceuticals Inc., Bridgewater, NJ, USA)
Luis Castro (Merck Neuroscience Research Centre, Harlow, UK)
Jeffrey Conn (Merck Research Laboratories, West Point, PA, USA)
Joseph T. Coyle (Harvard Medical School, Belmont, MA, USA)
Errol B. De Souza (Archemix Corporation, Cambridge, MA, USA)
H. Christian Fibiger (Lilly Research Laboratories., Indianapolis, IN, USA)
Timothy C. Gallagher (University of Bristol, Bristol, UK)
Mark A. Geyer (UCSD School of Medicine, La Jolla, CA, USA)
Franz F. Hefti (Rinat Neuroscience Corporation, Palo Alto, CA, USA)
Stephen Heinemann (Salk Institute, San Diego, CA, USA)
Raymond G. Hill (Merck Neuroscience Research Centre, Harlow, UK)
Robert L. Hudkins (Cephalon Inc., West Chester, PA, USA)
Varghese John (Elan Pharmaceuticals, USA)
Walter H. Kaye (WPIC UPMC, Pittsburgh, PA, USA)
John Kelsoe (UCSD School of Medicine, La Jolla, CA, USA)
Grant A. Krafft (Northwestern University, Evanston, IL, USA)
G. Kenneth Lloyd (Nereus Pharmaceuticals Inc., San Diego, CA, USA)
Ralph Martins (Univ. of Western Australia, Western Australia, Australia)
Jeffrey F. Mckelvy (Avera Pharmaceuticals, San Diego, CA, USA)
Ian McDonald (Pharmaxis Ltd, Frenchs Forest, NSW, Australia)
Frédérique Menzaghi (Arena Pharmaceuticals, San Diego, CA, USA)
Brian W. Metcalf (Kosan Biosciences Inc., Hayward, CA, USA)
Richard J. Miller (Northwestern University, Evanston, IL, USA)
Gregory S. Naeve (Parallax Biosystems, Inc, San Diego, CA, USA)
Eric Nestler (UT Southwestern Medical Center, Dallas, TX, USA)
Paul Newhouse (University of Vermont, Burlington, VT, USA)
Michael G. Palfreyman (Psychiatric Genomics, Inc., Gaithersburg, MD, USA)
Roberto Pellicciari (University of Perugia, Perugia, Italy)
Shafiqur Rahman (South Dakota State University, Brookings, SD, USA)
David R. Rubinow (NIMH, NIH, Bethesda, MD, USA)
Robert Schwarcz (Maryland Psychiatric Res. Ctr., Baltimore, MD, USA)
Emanuele Sher (Lilly Research Centre, Surrey, UK)
Judith A. Siuciak (Bristol-Myers Squibb Co., Wallingford, CT, USA)
Paul A. Slesinger (Salk Institute for Biological Studies, La Jolla, CA, USA)
Solomon H. Snyder (Johns Hopkins University, Baltimore, MD, USA)
Michael Spedding (Institut de Recherches Int. Servier, Neuilly sur Seine, France)
Neal R. Swerdlow (UCSD School of Medicine, La Jolla, CA, USA)
Carol A. Tamminga (Maryland Psychiatric Res. Ctr., Baltimore, MD, USA)
Rudolph E. Tanzi (Massachusetts Gen. Hosp., Charlestown MA, USA)
Mark Tricklebank (Lilly Research Centre, Surrey, UK)
Susan Wonnacott (University of Bath, Bath, UK)
Mitsuhiro Yoshioka (Hokkaido University, Sapporo, Japan)